Literature DB >> 21745507

Extended cyclosporine delivery by silicone-hydrogel contact lenses.

Cheng-Chun Peng1, Anuj Chauhan.   

Abstract

Cyclosporine A (CyA) is effective in treating chronic dry eyes and contact lens mediated dry eyes. CyA is delivered through eye drops of an oil-in-water emulsion, which has a small residence time in the eyes, leading to low bioavailability. Here we explore delivery of CyA from contact lenses to provide controlled and extended drug delivery with an increased bioavailability due to enhanced ocular residence time. Loading and release profiles of CyA from commercial contact lenses are presented to show that 1-DAY ACUVUE® releases CyA for about a day and extended wear silicone hydrogel (SiH) lenses release CyA for about 2-weeks. The longer duration from SiH lenses compared to the 1-DAY ACUVUE®lens is due to larger partition coefficients in the gel. A novel approach is presented for increasing release duration from the SiH lenses to the desired 1-month through incorporation of Vitamin E. The results show that Vitamin E loaded lenses can provide CyA release within the therapeutic window for a period of about a month. This pilot study demonstrates the promising potential of delivering CyA from contact lens for treatment of chromic dry eyes and contact lens mediated dry eyes.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21745507     DOI: 10.1016/j.jconrel.2011.06.028

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

1.  Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation.

Authors:  Phillip Dixon; Tanushri Ghosh; Kalyani Mondal; Aditya Konar; Anuj Chauhan; Sarbani Hazra
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

Review 2.  Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation.

Authors:  Michelle L Ratay; Elena Bellotti; Riccardo Gottardi; Steven R Little
Journal:  Adv Healthc Mater       Date:  2017-10-16       Impact factor: 9.933

3.  Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence.

Authors:  Philip Ames; Anat Galor
Journal:  Clin Investig (Lond)       Date:  2015

4.  Extended release of dexamethasone from oleogel based rods.

Authors:  Russell Macoon; Timothy Guerriero; Anuj Chauhan
Journal:  J Colloid Interface Sci       Date:  2019-07-31       Impact factor: 8.128

Review 5.  Nanoparticles for drug delivery to the anterior segment of the eye.

Authors:  Dileep R Janagam; Linfeng Wu; Tao L Lowe
Journal:  Adv Drug Deliv Rev       Date:  2017-04-06       Impact factor: 15.470

6.  Extended release of timolol from nanoparticle-loaded fornix insert for glaucoma therapy.

Authors:  Hyun Jung Jung; Anuj Chauhan
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-03       Impact factor: 2.671

7.  In Situ Measurement of Thermodynamic Partitioning in Open Hydrogels.

Authors:  Alison Su; Benjamin E Smith; Amy E Herr
Journal:  Anal Chem       Date:  2019-12-10       Impact factor: 6.986

Review 8.  An overview on dry eye treatment: approaches for cyclosporin a delivery.

Authors:  Burçin Yavuz; Sibel Bozdağ Pehlivan; Nurşen Unlü
Journal:  ScientificWorldJournal       Date:  2012-04-24

Review 9.  Nanomedicine approaches for corneal diseases.

Authors:  Shyam S Chaurasia; Rayne R Lim; Rajamani Lakshminarayanan; Rajiv R Mohan
Journal:  J Funct Biomater       Date:  2015-04-30

Review 10.  Nanotechnology approaches for ocular drug delivery.

Authors:  Qingguo Xu; Siva P Kambhampati; Rangaramanujam M Kannan
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.